Skip to main content

Table 3 Intra-Aortic Balloon Pump and Antithrombotic Characteristics

From: Comparison of anticoagulated versus non-anticoagulated patients with intra-aortic balloon pumps

 

Heparin group (n = 82)

Non-heparin group (n = 65)

Time on IABP (hours)a

42 (30–68)

26 (17–45)

Time in 1:1 Settinga

36 (18.8–62.5)

19 (10–40)

Time in 1:2 Settinga

5 (3–11)

4 (2–14)

Time in 1:3 Settinga

2 (1–3)

1

PTT goal range 60–80

54 (65.9)

N/A

PTT goal range 50–70

21 (25.6)

N/A

Other PTT goal

7 (8.5)

N/A

Rate of heparin (units/kg/hr)a

12 (9–15)

N/A

Time on heparin (hours)a

56 (32–89

N/A

Percent of time in therapeutic rangea

44.8 ± 27.8

N/A

Received concomitant aspirin monotherapy

42 (51.2)

42 (64.6)

Received concomitant dual antiplatelet therapyc

22 (26.8)

9 (13.8)

Received concomitant dual antiplatelet therapy with clopidogrel and aspirin

14 (17.1)

9 (13.8)

Received concomitant dual antiplatelet therapy with ticagrelor and aspirin

8 (9.8)

0

  1. All values are n(%) unless otherwise specified
  2. PTT partial thromboplastin time
  3. amean +/−SD
  4. bmedian (IQR)
  5. cDual antiplatelet therapy is defined as being on both aspirin and a P2Y12 inhibitor